JP2022546701A - 新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム - Google Patents

新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム Download PDF

Info

Publication number
JP2022546701A
JP2022546701A JP2022513214A JP2022513214A JP2022546701A JP 2022546701 A JP2022546701 A JP 2022546701A JP 2022513214 A JP2022513214 A JP 2022513214A JP 2022513214 A JP2022513214 A JP 2022513214A JP 2022546701 A JP2022546701 A JP 2022546701A
Authority
JP
Japan
Prior art keywords
crispr
nucleic acid
sequence
seq
target nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022513214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546701A5 (https=
JPWO2021041569A5 (https=
Inventor
デイビッド エー． スコット，
デイビッド アール． チェン，
ウィンストン エックス． ヤン，
ティア エム． ディトマソ，
Original Assignee
アーバー バイオテクノロジーズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アーバー バイオテクノロジーズ， インコーポレイテッド filed Critical アーバー バイオテクノロジーズ， インコーポレイテッド
Publication of JP2022546701A publication Critical patent/JP2022546701A/ja
Publication of JP2022546701A5 publication Critical patent/JP2022546701A5/ja
Publication of JPWO2021041569A5 publication Critical patent/JPWO2021041569A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2022513214A 2019-08-27 2020-08-26 新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム Pending JP2022546701A (ja)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US201962892434P 2019-08-27 2019-08-27
US201962892390P 2019-08-27 2019-08-27
US201962892382P 2019-08-27 2019-08-27
US201962892358P 2019-08-27 2019-08-27
US201962892446P 2019-08-27 2019-08-27
US62/892,390 2019-08-27
US62/892,434 2019-08-27
US62/892,382 2019-08-27
US62/892,446 2019-08-27
US62/892,358 2019-08-27
US201962893064P 2019-08-28 2019-08-28
US201962893059P 2019-08-28 2019-08-28
US62/893,064 2019-08-28
US62/893,059 2019-08-28
US201962896277P 2019-09-05 2019-09-05
US62/896,277 2019-09-05
PCT/US2020/048037 WO2021041569A1 (en) 2019-08-27 2020-08-26 Novel crispr dna targeting enzymes and systems

Publications (3)

Publication Number Publication Date
JP2022546701A true JP2022546701A (ja) 2022-11-07
JP2022546701A5 JP2022546701A5 (https=) 2023-09-04
JPWO2021041569A5 JPWO2021041569A5 (https=) 2023-09-04

Family

ID=74683321

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513214A Pending JP2022546701A (ja) 2019-08-27 2020-08-26 新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム

Country Status (7)

Country Link
US (1) US20230016656A1 (https=)
EP (1) EP4021924A4 (https=)
JP (1) JP2022546701A (https=)
CN (1) CN114729011A (https=)
AU (1) AU2020340353A1 (https=)
CA (1) CA3152788A1 (https=)
WO (1) WO2021041569A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3117730A1 (en) 2018-11-09 2020-05-14 Inari Agriculture, Inc. Rna-guided nucleases and dna binding proteins
IL308806A (en) 2021-06-01 2024-01-01 Arbor Biotechnologies Inc Gene editing systems including nuclease crisper and their uses
WO2024173645A1 (en) 2023-02-15 2024-08-22 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
WO2024078645A2 (zh) * 2023-12-28 2024-04-18 广州瑞风生物科技有限公司 Cas蛋白及其应用
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2025201481A1 (en) * 2024-03-29 2025-10-02 Yoltech Therapeutics Co., Ltd Crispr-cas systems
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018035250A1 (en) * 2016-08-17 2018-02-22 The Broad Institute, Inc. Methods for identifying class 2 crispr-cas systems
WO2018064352A1 (en) * 2016-09-30 2018-04-05 The Regents Of The University Of California Rna-guided nucleic acid modifying enzymes and methods of use thereof
US20190002889A1 (en) * 2017-06-30 2019-01-03 Arbor Biotechnologies, Inc. Novel crispr rna targeting enzymes and systems and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018035250A1 (en) * 2016-08-17 2018-02-22 The Broad Institute, Inc. Methods for identifying class 2 crispr-cas systems
WO2018064352A1 (en) * 2016-09-30 2018-04-05 The Regents Of The University Of California Rna-guided nucleic acid modifying enzymes and methods of use thereof
US20190002889A1 (en) * 2017-06-30 2019-01-03 Arbor Biotechnologies, Inc. Novel crispr rna targeting enzymes and systems and uses thereof
US20190002875A1 (en) * 2017-06-30 2019-01-03 Arbor Biotechnologies, Inc. Novel crispr rna targeting enzymes and systems and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MOLECULAR CELL, vol. 60, JPN6024033951, 2015, pages 385 - 397, ISSN: 0005401573 *
NATURE, vol. 542, JPN6024033949, 2017, pages 237 - 241, ISSN: 0005401571 *
THE CRISPR JOURNAL, vol. 1, no. 2, JPN6024033950, 2018, pages 171 - 181, ISSN: 0005401572 *

Also Published As

Publication number Publication date
US20230016656A1 (en) 2023-01-19
EP4021924A1 (en) 2022-07-06
EP4021924A4 (en) 2024-02-07
AU2020340353A1 (en) 2022-03-24
WO2021041569A1 (en) 2021-03-04
CN114729011A (zh) 2022-07-08
CA3152788A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
US11667904B2 (en) CRISPR-associated systems and components
JP7705382B2 (ja) 新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム
JP2022546701A (ja) 新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム
JP2022546594A (ja) 新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム
JP2022540153A (ja) 新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム
US20220315913A1 (en) Novel crispr dna targeting enzymes and systems
CA3093580A1 (en) Novel crispr dna and rna targeting enzymes and systems

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230825

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230825

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240827

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250123

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250318